Javascript must be enabled to continue!
Modulation of AMPA Receptors in Cultured Cortical Neurons Induced by the Antiepileptic Drug Levetiracetam
View through CrossRef
Summary: Purpose:The present study explores the hypothesis that the antiepileptic mechanism of action of levetiracetam (LEV) is related to effects on α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptor channels in mouse cortical neurons in culture.Methods:The neurons were subjected to the whole‐cell configuration of the patch‐clamp recording technique and were 8–12 days old in culture.Results:Kainate elicited concentration‐dependent (EC50= 80 μM) inward currents in all the patched cells. LEV (5–200 μM) itself did not induce inward or outward currents on all patched neurons, whereas it was effective on the kainate‐ and AMPA‐induced current because it significantly decreased the amplitude of these currents. LEV was also able to significantly decrease the total membrane conductance during kainate perfusion, indicating that its effect was not dependent on the cellular voltage membrane potential. Further evidence that LEV modulated the ionotropic non‐NMDA receptors came from the analysis of miniature excitatory postsynaptic currents (mEPSCs). In fact, LEV significantly decreased both the amplitude and the frequency of mEPSCs, as shown by the relative cumulative distributions.Conclusions:These results reveal that AMPA receptors are modulated by LEV because a significant decrease in the kainate‐ and AMPA‐induced currents and a decrease in amplitude and in frequency of mEPSCs have been observed in cortical neurons in culture. The described effect of LEV on AMPA receptors in cortical neurons is probably due to the etheromeric composition of the receptors and may be considered as a possible new antiepileptic mechanism of action.
Title: Modulation of AMPA Receptors in Cultured Cortical Neurons Induced by the Antiepileptic Drug Levetiracetam
Description:
Summary: Purpose:The present study explores the hypothesis that the antiepileptic mechanism of action of levetiracetam (LEV) is related to effects on α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptor channels in mouse cortical neurons in culture.
Methods:The neurons were subjected to the whole‐cell configuration of the patch‐clamp recording technique and were 8–12 days old in culture.
Results:Kainate elicited concentration‐dependent (EC50= 80 μM) inward currents in all the patched cells.
LEV (5–200 μM) itself did not induce inward or outward currents on all patched neurons, whereas it was effective on the kainate‐ and AMPA‐induced current because it significantly decreased the amplitude of these currents.
LEV was also able to significantly decrease the total membrane conductance during kainate perfusion, indicating that its effect was not dependent on the cellular voltage membrane potential.
Further evidence that LEV modulated the ionotropic non‐NMDA receptors came from the analysis of miniature excitatory postsynaptic currents (mEPSCs).
In fact, LEV significantly decreased both the amplitude and the frequency of mEPSCs, as shown by the relative cumulative distributions.
Conclusions:These results reveal that AMPA receptors are modulated by LEV because a significant decrease in the kainate‐ and AMPA‐induced currents and a decrease in amplitude and in frequency of mEPSCs have been observed in cortical neurons in culture.
The described effect of LEV on AMPA receptors in cortical neurons is probably due to the etheromeric composition of the receptors and may be considered as a possible new antiepileptic mechanism of action.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Epilepsy outcomes with immediate- and extended-release levetiracetam in idiopathic generalized seizures
Epilepsy outcomes with immediate- and extended-release levetiracetam in idiopathic generalized seizures
Idiopathic generalized epilepsy is a neurological disorder characterized by recurrent seizure attacks associated with sudden loss of consciousness. Seizures may present as generali...
AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked
AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked
Although cultured astrocytes express functional glutamate receptors, they are generally resistant to excitotoxic cell death. We explored the role of receptor desensitization in glu...
Efficacy Of Phentoin Versus Levetiracetam In Children Presenting With Status Epilepticus At Tertiary Care Hospital Quetta
Efficacy Of Phentoin Versus Levetiracetam In Children Presenting With Status Epilepticus At Tertiary Care Hospital Quetta
Objectives: To assess and evaluate how well Phenytoin performs in treating status epilepticus as compared to Levetiracetam, in children at a tertiary care hospital in Quetta.
Study...
The safety of rapid infusion levetiracetam: A systematic review
The safety of rapid infusion levetiracetam: A systematic review
AbstractEpilepsy is a common diagnosis and can quickly progress to status epilepticus which requires rapid treatment. Levetiracetam is a frequent treatment choice in these situatio...
Variable distributions of Ca(2+)-permeable and Ca(2+)-impermeable AMPA receptors on embryonic rat dorsal horn neurons
Variable distributions of Ca(2+)-permeable and Ca(2+)-impermeable AMPA receptors on embryonic rat dorsal horn neurons
1. By measuring the apparent reversal potential (aErev) of kainate- and alpha-amino-3-hydroxyl-5-methyl-4-isoxazole propionic acid (AMPA)-evoked currents associated with changes in...
Levetiracetam-induced Rhabdomyolysis - A Rare Complication
Levetiracetam-induced Rhabdomyolysis - A Rare Complication
Background: Levetiracetam is an anti-epileptic drug that works by modulation of synaptic neurotransmitter release through binding to the synaptic vesicle protein 2A. Levetiracetam ...
Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson’s Disease: A Systematic Review
Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson’s Disease: A Systematic Review
Background:
Levetiracetam, a novel antiepileptic drug, has shown antidyskinetic effects in
experimental animal models of Parkinson's disease (PD). The tolerability and efficacy of ...

